Sonoma Pharmaceuticals (SNOA) EBITDA Margin (QoQ) (2010 - 2025)
Sonoma Pharmaceuticals (SNOA) EBITDA Margin (QoQ) (2010 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn |
| 10 | Sonoma Pharmaceuticals | 1.90 Mn | -659,569.98 | 1.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -896.00 |
| Sep 30, 2025 | 496.00 |
| Jun 30, 2025 | 510.00 |
| Mar 31, 2025 | 2,013.00 |
| Dec 31, 2024 | -244.00 |
| Sep 30, 2024 | 2,607.00 |
| Jun 30, 2024 | -3,157.00 |
| Mar 31, 2024 | -999.00 |
| Dec 31, 2023 | 4,401.00 |
| Sep 30, 2023 | -3,567.00 |
| Jun 30, 2023 | -822.00 |
| Mar 31, 2023 | 3,963.00 |
| Dec 31, 2022 | -2,633.00 |
| Sep 30, 2022 | -765.00 |
| Jun 30, 2022 | 9,294.00 |
| Mar 31, 2022 | -8,207.00 |
| Dec 31, 2021 | -2,585.00 |
| Sep 30, 2021 | 1,255.00 |
| Jun 30, 2021 | 16,416.00 |
| Mar 31, 2021 | -19,312.00 |